Approval · Notice of Compliance 27099 · 2021
DIPRIVAN 1%: Notice of Compliance 27099
Issued November 25, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27099
- Date
- November 25, 2021
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph and migrate the Product Monograph to the 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIPRIVAN 1% | Not yet assigned | — |
Medicinal ingredients
- PROPOFOL 10 MG per ML